Trial Profile
An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- Sponsors CSL Behring
- 12 Sep 2014 New trial record